$APYX News

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

Apyx Medical Publishes New Clinical Data In Aesthetic Surgery Journal Open Forum Highlighting Approach To Improving Cellulite And Skin Laxity

Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

Apyx Medical Announces Publication Of A New Retrospective Investigator-Initiated Study In Plastic And Reconstructive Surgery - Global Open

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50

Apyx Medical (APYX) Q1 2026 Earnings Transcript

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

NewBeauty Award Win Keeps Attention on Apyx Medical’s Renuvion Growth Strategy

Apyx Medical Q1 Earnings Call Highlights

APYX MEDICAL CORP (NASDAQ:APYX) Surges After Q1 Beat

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Apyx Medical Raises FY2026 Sales Guidance from $57.500M-$58.500M to $59.000M-$60.000M vs $57.988M Est

Apyx Medical Q1 EPS $(0.05) Beats $(0.10) Estimate, Sales $12.490M Beat $10.868M Estimate

How The Apyx Medical (APYX) Story Is Shifting With 2026 Guidance And New Growth Drivers

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

How The Apyx Medical (APYX) Narrative Is Shifting With New Targets Guidance And Growth Drivers

Is Agenus (AGEN) Outperforming Other Medical Stocks This Year?

Why The Apyx Medical (APYX) Story Is Shifting With New Guidance And GLP-1 Demand